Open AccessA ‘tailor made’ vaccine trialled as part of public health response to group B meningococcal epidemic in New Zealand
Author(s) -
Jens J. Holst,
Ingeborg S. Aaberge,
Philipp Oster,
Diana Len,
D Martin,
J O'Hallahan,
K Nord,
H Nøkleby,
L M Næss,
L M Næss,
P Kristiansen,
A G Skryten,
K Bryn,
A Aase,
R Rappuoli,
E Rosenqvist
Publication year - 2003
Publication title -
weekly releases (1997–2007)
Language(s) - English
Resource type - Journals
ISSN - 9999-1233
DOI - 10.2807/esw.07.30.02262-en
Subject(s) - meningococcal vaccine , meningococcal disease , public health , medicine , meningococcal infections , group b , neisseria meningitidis , virology , family medicine , immunology , biology , immunization , nursing , antigen , genetics , bacteria
New Zealand has experienced an epidemic of serogroup B meningococcal infection since 1991
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom